Serdia Pharmaceuticals

Serdia Pharmaceuticals is the Indian commercial subsidiary of Servier, a leading international independent pharmaceutical company governed by a non-profit foundation. Founded in 1987 and headquartered in Mumbai, Serdia specializes in the therapeutic areas of cardiovascular disease, endocrinology, and venous disorders. The company is well-regarded for its portfolio of research-driven brands, including Daflon for venous circulation, Diamicron for diabetes management, and Coversyl for hypertension. Serdia maintains a significant presence in India through its dedicated field force and manufacturing facilities, focusing on the ethical promotion of innovative small molecule therapies and medical education.